Pimavanserin: A Solution for Psychosis in Parkinson's Disease?

<p>This episode explores the controversial role of pimavanserin in treating psychosis in Parkinson's disease. How does it compare with quetiapine or clozapine? Sneak peek: All of these medications are effective, yet none distinctly surpasses the others.</p> <p>Faculty: Jim Phelps, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC270" target="_blank" rel="noopener"><strong>Learn more about our membership here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/quick-take-vol-51-2726?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC270" target="_blank" rel="noopener"><strong>Earn 0.5 CMEs: Quick Take Vol. 51</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/comparative-efficacy-safety-and-acceptability-of-pimavanserin-and-other-atypical-antipsychotics-for-parkinsons-disease-psychosis-systematic-review-and-network-meta-analysis-2726-5477?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC270" target="_blank" rel="noopener"><strong>Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson’s Disease Psychosis: Systematic Review and Network Meta-Analysis</strong></a></li> </ul>